|
MechanismTranscription factors and related regulators inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Avergen Pharmaceuticals GmbH
0 Patents (Medical) associated with Avergen Pharmaceuticals GmbH
100 Deals associated with Avergen Pharmaceuticals GmbH
100 Translational Medicine associated with Avergen Pharmaceuticals GmbH